News for Pulse Biosciences, Inc. (PLSE)

See how Pulse Biosciences, Inc.'s stock surged 100% despite no clear commercialization timeline, management turnover, and scarce coverage. Click to read more on PLSE.

Despite promising technology and FDA clearances, Pulse Biosciences lacks a revenue stream and remains in the testing phase with no commercialized products. Read why PLSE is a hold.

SOUTH SAN FRANCISCO, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. ( CRVS), a clinical-stage biopharmaceutical company, announced to

**media[590863]**

Operator: Thank you for standing by. My name is Louella, and I will be your conference operator today.

On March 28, 2025, Pulse Biosciences Inc (PLSE) released its 8-K filing, detailing the company's financial performance for the fourth quarter and full year endi

Total GAAP Costs and Expenses: Increased by $7.7 million to $20.3 million in Q4 2024 compared to $12.5 million in the prior year period.Non-Cash Stock-Based Co

Mar 27, 2025 / 08:30PM GMTOperator Thank you for standing by. My name is Malia, and I will be your conference operator today. At this time, I would like to welc

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsPhilip Trip Taylor - Investor...

Summary Pulse Biosciences Inc (PLSE), a leader in bioelectric medicine, has announced that it will release its financial results for the fourth quarter and full

Summary Pulse Biosciences Inc (PLSE), a leader in bioelectric medicine, announced on February 27, 2025, and March 3, 2025, that its Compensation Committee has g

Pulse Biosciences, Inc. (Nasdaq: PLSE) , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablationâ„¢ (nanosecond PFA or nsPFAâ„¢) techno

Summary Pulse Biosciences Inc (PLSE), a pioneering company in bioelectric medicine, announced its participation in the TD Cowen 45th Annual Health Care Conferen

Colorado-based Aclarion, Inc. (ACON) is up over 30 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Colorado-based Aclarion, Inc. (ACON) is up over 30 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Summary Pulse Biosciences Inc (PLSE), a leader in bioelectric medicine, announced significant findings from its first-in-human feasibility study of the Nanoseco

Summary Pulse Biosciences Inc (PLSE), a leader in bioelectric medicine, announced that its cutting-edge Nanosecond Pulsed Field Ablationâ„¢ (nsPFAâ„¢) technolog

Summary Pulse Biosciences Inc (PLSE), a company specializing in Nanosecond Pulsed Field Ablationâ„¢ technology, announced the appointment of Paul A. LaViolette

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the ”œCompany” or ”œPulse Biosciences”), a company leveraging its novel and proprietary Nanosecond Pulsed Field A